T. Chanda et al. / Tetrahedron 70 (2014) 2190e2194
2193
4. Experimental section
2H); 13C NMR (75 MHz, CDCl3)
d
203.8, 157.9, 143.7, 135.8, 135.4,
133.0, 129.4, 128.4, 126.4, 125.1, 123.0, 77.8, 55.7.
4.1. General
4.4.4. 3-(3-Chlorophenyl)-3-hydroxy-2,3-dihydro-1H-inden-1-one
1H and 13C NMR spectra were recorded at 300 and 75 MHz,
(2f). Orange sticky solid; 1H NMR (300 MHz, CDCl3)
d 7.67e7.57 (m,
respectively. Chemical shift (
d
) values are given in parts per million
2H), 7.46e7.35 (m, 3H), 7.21e7.09 (m, 3H), 3.94 (s, 1H), 3.10 (dd,
(ppm) with reference to tetramethylsilane (TMS) as the internal
standard. Coupling constant (J) values are given in Hertz (Hz). High
resolution mass spectra were recorded using ESI method. Organic
solvents used were dried by standard methods wherever necessary.
Commercially obtained reagents were used as such without further
purification. All the reactions were monitored by thin-layer chro-
matography (TLC) using silica gel 60 F254 precoated plates. Column
chromatography was carried out using silica gel with
100e200 mesh or with anhydrous alumina. Mixture of hexane/
ethyl acetate or MeOH/DCM in appropriate proportion (determined
by TLC analysis) was used as eluent solvent system.
J1¼18.9 Hz, J2¼27 Hz, 2H); 13C NMR (75 MHz, CDCl3)
d 203.7, 157.8,
147.3, 135.9, 135.5, 134.3, 129.6, 129.6, 127.4, 125.3, 125.1, 123.3,
123.1, 77.8, 55.7; HRMS (ESI-TOF) of
C15H11ClO2¼281.0340
[MþNaþ] (calculated 281.0340).
4.4.5. 6-Chloro-3-hydroxy-3-(pyridin-3-yl)-2,3-dihydro-1H-inden-
1-one (2k). Brown sticky solid; 1H NMR (300 MHz, CDCl3)
8.52
d
(broad, 1H), 8.35 (broad, 1H), 7.70e7.59 (m, 3H), 7.34e7.26 (m, 3H),
3.26 (dd, J1¼19.2 Hz, J2¼32.1 Hz, 2H); 13C NMR (75 MHz, CDCl3)
d
201.3, 155.5, 148.2, 146.3, 140.9, 137.2, 136.4, 136.0, 133.3, 126.6,
123.5, 123.1, 76.5, 56.0; HRMS (ESI-TOF) of C14H10ClNO2¼260.0471
[MþHþ] (calculated 260.0473).
4.2. Typical procedure for the synthesis of 2
4.4.6. 3-Phenylindenone9 (3a). Orange oil; 1H NMR (300 MHz,
One mmol of 1 was taken in a round bottom flask and dissolved
in DMSO (3 mL), 0.05 mmol (0.004 mL) of freshly prepared 50%
aqueous NaOH (2.5 g in 5 mL distilled water) was added and stirred
at room temperature. After completion of the reaction (monitored
by TLC), 30 mL water was added to it and product was extracted
with ethyl acetate (20 mLꢀ3). Combined organic layer was washed
with water and brine solution and dried over anhydrous Na2SO4.
Ethyl acetate was evaporated and crude was purified by column
chromatography using EtOAc/Hexane mixture as the mobile phase
and silica gel (100/200 mesh) as the stationary phase to afford pure
2.
CDCl3)
(s, 1H).
d 7.58 (broad, 1H), 7.44 (broad, 4H), 7.32e7.09 (m, 3H), 5.93
4.4.7. 13b-Phenylbenzo[a]indeno[1,2-c]fluorene-9,14(8bH,13bH)-di-
one (4a). Orange red solid; mp 254e257 ꢁC; 1H NMR (300 MHz,
CDCl3)
1H), 7.53e7.43 (m, 6H), 7.29e7.23 (m, 4H), 7.14 (d, J¼6.3 Hz, 2H),
3.98 (s, 1H); 13C NMR (75 MHz, CDCl3)
201.4, 194.7, 156.8, 151.8,
143.2, 141.3, 137.0, 134.8, 134.1, 133.7, 133.0, 132.4, 131.7, 131.2, 130.7,
129.0, 128.8, 127.8, 127.1, 126.6, 125.6, 123.4, 122.6, 122.4, 110.0,
100.6, 66.0, 51.6; CCDC 875292.
d
8.19e8.15 (m, 2H), 7.85e7.77 (m, 2H), 7.71 (t, J¼7.35 Hz,
d
4.3. Typical procedure for the synthesis of 4
4.4.8. 2,11-Dimethyl-13b-phenylbenzo[a]indeno
9,14(8bH,13bH)-dione (4b). Red solid; mp 262e264 ꢁC; 1H NMR
(300 MHz, CDCl3)
[1,2-c]fluorene-
One mmol of 1 was taken in a round bottom flask and dissolved
in DMSO (3 mL), 4 mmol (0.32 mL) of freshly prepared 50% aqueous
NaOH (2.5 g in 5 mL distilled water) was added and stirred at room
temperature. After completion of the reaction (monitored by TLC)
30 mL water was added to it and product was extracted with ethyl
acetate (20 mLꢀ3). Combined organic layer was washed with water
and brine solution and dried over anhydrous Na2SO4. Ethyl acetate
was evaporated and crude was purified by column chromatography
using EtOAc/Hexane mixture as eluent (4aei). In case of synthesis
of 4jel extraction was performed using solvent DCM instead of
EtOAc and column was done with MeOH/DCM solvent system in
appropriate proportion using neutral alumina as stationary phase.
d
8.14 (d, J¼7.5 Hz, 1H), 8.05 (d, J¼8.1 Hz, 1H),
7.66e7.63 (m, 2H), 7.54e7.42 (m, 4H), 7.23e7.19 (m, 5H), 7.13 (d,
J¼6.6 Hz, 2H), 3.95 (s, 1H), 2.42 (s, 3H), 2.33 (s, 3H); 13C NMR
(75 MHz, CDCl3) d 201.6, 195.1, 154.5, 151.7, 143.6, 139.4, 138.5, 138.0,
137.2, 136.1, 134.2, 133.4, 132.9, 132.8, 131.6, 131.2, 130.4, 128.8,
128.3, 127.8, 127.0, 126.7, 125.7, 123.7, 123.4, 122.3, 66.2, 51.3, 21.2,
21.0; CCDC 898556.
4.4.9. 6-Methyl-13b-(m-tolyl)benzo[a]indeno[1,2-c]fluorene-
9,14(8bH,13bH)-dione (4c). Orange red solid; mp 256e258 ꢁC; 1H
NMR (300 MHz, CDCl3)
d
8.17 (d, J¼7.8 Hz, 1H), 7.96 (s, 1H), 7.83 (t,
J¼7.35 Hz, 2H), 7.70 (t, J¼7.35 Hz, 1H), 7.42e7.24 (m, 6H), 7.15 (t,
J¼7.95 Hz, 1H), 7.02 (d, J¼7.2 Hz, 1H), 6.90 (broad, 2H), 3.94 (s, 1H),
4.4. Characterization data of the synthesized molecules
2.46 (s, 3H), 2.23 (s, 3H); 13C NMR (75 MHz, CDCl3)
d 201.9, 194.7,
157.1, 151.8, 143.2, 141.4, 138.4, 137.5, 136.9, 134.7, 133.8, 132.9, 132.4,
132.0, 131.5, 131.2, 130.7, 129.0, 128.6, 128.0, 127.9, 127.7, 127.1, 126.3,
123.8, 123.4, 122.5, 122.4, 65.7, 51.7, 21.5, 21.5; HRMS (ESI-TOF) of
4.4.1. 3-Hydroxy-3-phenylindanone8 (2a). Yellow gelly; 1H NMR
(300 MHz, CDCl3)
7.41e7.31 (m, 2H), 7.24e7.18 (m, 5H), 3.04 (s, 2H), 2.90 (broad, 1H);
13C NMR (75 MHz, CDCl3)
203.8, 158.2, 145.1, 135.7, 129.3, 128.4,
d
7.67 (d, J¼7.5 Hz, 1H), 7.56 (t, J¼7.05 Hz, 1H),
C
32H22O2¼439.1691 [MþHþ] (calculated 439.1693).
d
127.3, 127.2, 125.2, 125.1, 124.9, 123.0, 78.3, 55.9.
4.4.10. 2,11-Dichloro-13b-phenylbenzo[a]indeno
9,14(8bH,13bH)-dione (4d). Orange red solid; mp 285e287 ꢁC; 1H
NMR (300 MHz, CDCl3)
8.10 (d, J¼8.1 Hz, 2H), 7.79e7.38 (m, 7H),
7.25 (broad, 4H), 7.10e7.08 (m, 2H), 4.00 (s, 1H); 13C NMR (75 MHz,
CDCl3) 200.1, 193.1, 154.7, 151.8, 142.4, 139.1, 138.5, 135.5, 134.8,
[1,2-c]fluorene-
4.4.2. 3-Hydroxy-6-methyl-3-phenyl-2,3-dihydro-1H-inden-1-one
d
(2b). Yellow gelly; 1H NMR (300 MHz, CDCl3)
d
7.58 (s, 1H), 7.48 (d,
J¼7.8 Hz, 1H), 7.34e7.25 (m, 6H), 3.16 (s, 2H), 2.50 (s, 1H), 2.44 (s,
3H); 13C NMR (75 MHz, CDCl3)
203.9, 155.9, 145.4, 139.5, 136.8,
d
d
134.7, 134.0,133.6, 133.2, 132.2,131.9, 131.8, 129.0,128.1, 127.6, 127.4,
126.5, 125.7, 123.3, 123.2, 66.2, 51.3; CCDC 891987.
135.9, 128.3, 127.1, 124.9, 122.8, 78.0, 56.3, 21.1; HRMS (ESI-TOF) of
C
16H14O2¼261.0886 [MþNaþ].
4.4.11. 7-Chloro-13b-(4-chlorophenyl)benzo[a]indeno[1,2-c]fluorene-
9,14(8bH,13bH)-dione (4e). Orange red solid; mp 228e230 ꢁC; 1H
4.4.3. 3-(4-Chlorophenyl)-3-hydroxy-2,3-dihydro-1H-inden-1-one
(2e). Light yellow sticky solid; 1H NMR (300 MHz, CDCl3)
NMR (300 MHz, CDCl3)
d
8.15e8.07 (m, 2H), 7.86 (d, J¼7.5 Hz, 1H),
d
7.64e7.56 (m, 2H), 7.44 (t, J¼7.2 Hz, 1H), 7.36 (d, J¼7.5 Hz, 1H),
7.73 (t, J¼7.95 Hz, 2H), 7.44 (broad, 5H), 7.32e7.22 (m, 3H), 7.06 (d,
7.26e7.23 (m, 4H), 4.04 (s, 1H), 3.09 (dd, J1¼19.05 Hz, J2¼29.9 Hz,
J¼8.4 Hz, 2H), 3.87 (s, 1H); 13C NMR (75 MHz, CDCl3þDMSO-d6)